Skip to main content
. 2021 Mar 31;320(5):R757–R769. doi: 10.1152/ajpregu.00232.2020

Table 2.

Cardiac function during whole body heating and normothermic time control trials

Baseline Prior to Exercise
SV, mL
 WBH 117 ± 14 123 ± 17#
 NT 114 ± 16 116 ± 16
CO, L/min
 WBH 7.3 ± 1.4 8.4 ± 1.9*#
 NT 6.9 ± 1.3 7.0 ± 1.3
TPR, mmHg·min/L
 WBH 12.9 ± 3.2 10.9 ± 3.0*#
 NT 13.6 ± 2.8 14.0 ± 3.0
Sm, cm/s
 WBH 9.54 ± 1.26 10.04 ± 1.79
 NT 9.77 ± 1.51 9.59 ± 1.72
E, cm/s
 WBH 74.0 ± 14 68.9 ± 13.8*
 NT 71.8 ± 15.5 72.3 ± 12.5
Em, cm/s
 WBH 10.35 ± 1.42 9.37 ± 1.52*#
 NT 10.56 ± 1.81 10.53 ± 1.75
E/Em
 WBH 7.20 ± 1.22 7.55 ± 2.08
 NT 6.93 ± 1.62 6.96 ± 1.28
Am, cm/s
 WBH 12.18 ± 2.29 12.59 ± 3.97
 NT 12.11 ± 2.73 12.05 ± 2.96

Two-way repeated-measures ANOVA was used for statistical analysis. *P < 0.05 vs. respective baseline; #P < 0.05 vs. normothermic control trial. Subject number n = 14. Am, second negative diastolic velocity when the mitral annulus moves toward the base away from the apex; CO, cardiac output; E, early diastolic mitral flow; E/Em, ratio of early diastolic mitral flow over Em; Em, first rapid negative diastolic velocity when the mitral annulus moves toward the base away from the apex; NT, normothermic time control trial; Sm, positive systolic velocity when the mitral ring moved toward the cardiac apex; SV, stroke volume; TPR, total peripheral resistance; WBH, whole body heating trial.